- Published at
- by gurufocus.com
positive
positive
Regen BioPharma, Inc. to Seek Orphan Drug Designation for Lead Product | RGBP Stock News
Regen BioPharma (RGBP) to seek Orphan Drug Designation for HemaXellerate. FDA clearance received for Phase I clinical trials, with completion expected in 12